Diabeto, a technology company focused on diabetes management, was acquired by Livongo, a leader in chronic condition management technology. Diabeto developed a Bluetooth-powered hardware device that wirelessly transmits glucose readings from a glucometer into smartphones. This acquisition aimed to expand options for Livongo's members, offering a more affordable connectivity solution for diabetes care management. Diabeto's business, which works with consumers and enterprise partners, continues to operate post-acquisition. This acquisition aligns with Livongo's mission to drive healthier and better lives for people with chronic conditions through data science and behavior change.
A Bluetooth-powered hardware device for glucose monitoring, An ecosystem of tools for diabetes management (details not specified), Biopharmaceutical solutions for type-1 diabetes treatment (preclinical and clinical development stages)
Remote patient monitoring services, Chronic disease management solutions, Wellness solutions for diabetes care
Diabeto Medtech
Diabeto medtech specializes in diabetes care, offering monitoring tools, disease management solutions, and pioneering type-1 diabetes therapies.
602, Sir Mathuradas Vasanji Rd, Chakala, Andheri East, Mumbai, Maharashtra 400053
June 3, 2014
Maharashtra, Mumbai
At Mocero Health, we are committed to maintaining the trust and confidence of our visitors and users. This Index Data Usage Notice explains how we collect, use, and share data related to the various indices and aggregated metrics presented on our site. Index data on Mocero Health is generated through a combination of proprietary algorithms, user interactions, and publicly available health data. This may include, but is not limited to, health condition prevalence rates, treatment effectiveness scores, healthcare facility ratings, and user search trends. If you have concerns about how your data is used or wish to exercise your rights, please contact us at +91-9500115161. By using Mocero Health, you acknowledge and agree to the collection, use, and sharing of index data as described in this notice.
The information provided on this website is intended for general and educational purposes only. We reserve the right to modify this content policy at any time. Changes will be effective immediately upon posting the revised policy. Your continued use of the platform after any changes signifies your agreement to the new terms. If you have concerns about how your data is used or wish to exercise your rights, please contact us at +91-9500115161. By using this site, you acknowledge and agree that you have read and understood this Content Disclaimer.
Stay up-to-date with news about health-tech startups, compiled and presented in a centralized platform.